CompanyJuly 27, 2026630 Views
Huayuu Biopharma Completes Series B Funding
The company successfully completed Series B funding .
Hangzhou Huayuu Biopharma Co., Ltd. (HUAYUU) recently announced the completion of Series B funding , led by several renowned investment institutions. The funds will be used to accelerate clinical advancement of core pipelines and industrial base construction.
Related News

November 1, 2026
Huayuu Independent Station official website updates multiple language versions
The official website of Huayuu Independent Station has newly launched German, Spanish, and French versions.

October 31, 2026
In-Cosmetics Asia 2026
The in cosmetics Asia2026 will be held from November 3-5, 2026 at the BITEC exhibition hall in Bangkok, Thailand.

October 24, 2026
The China National Intellectual Property Administration accepts the trademark registration submitted by Huayuu Biomedical ®️
The China National Intellectual Property Administration accepts the registration of new brand trademarks submitted by Huayuu Biomedical ®️
